Back
MFS Multimarket Income Trust Vs. Summit Therapeutics Industry Stock Comparison
Sell
39
MMT
MFS Multimarket Income Trust
Last Price:
4.83
Seasonality Move:
-1.82%
Buy
75
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Sell
39
MFS Multimarket Income Trust (MMT)
is a Sell
Is MFS Multimarket Income Trust a Buy, Sell or Hold?
- The current MFS Multimarket Income Trust [MMT] share price is $4.83. The Score for MMT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- MMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $24.55. The Score for SMMT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MMT Stock Price Chart
What is MFS Multimarket Income Trust's stock price today?
-
The MFS Multimarket Income Trust share price today is $4.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MMT is experiencing slight buying pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $24.55
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
MMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 60.5 | Buy |
| Chaikin Money Flow: | 15819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.76 - 4.82) | Buy |
| Bollinger Bands (100): | (4.61 - 4.77) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.26 | Buy |
| Relative Strength Index (14 RSI): | 64.67 | Buy |
| Chaikin Money Flow: | -4213296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.3 - 23.18) | Buy |
| Bollinger Bands (100): | (4.28 - 15.36) | Buy |
MMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.82 | Buy |
| 20-day SMA: | 4.8 | Buy |
| 50-day SMA: | 4.76 | Buy |
| 200-day SMA: | 4.64 | Buy |
| 8-day EMA: | 4.82 | Buy |
| 20-day EMA: | 4.8 | Buy |
| 50-day EMA: | 4.76 | Buy |
| 200-day EMA: | 4.65 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.55 | Sell |
| 20-day SMA: | 17.97 | Buy |
| 50-day SMA: | 13.36 | Buy |
| 200-day SMA: | 6.72 | Buy |
| 8-day EMA: | 24.49 | Buy |
| 20-day EMA: | 19.78 | Buy |
| 50-day EMA: | 14.83 | Buy |
| 200-day EMA: | 8.2 | Buy |
MFS Multimarket Income Trust Earnings Growth & MMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
MFS Multimarket Income Trust Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||